See also this year's filing and all EDGAR filings for this company.
PDF Report 0001534248_2022_Chemomab_Therapeutics_Ltd.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001534248')"} |
Graph
Absolute values for 0001534248, Chemomab Therapeutics Ltd.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 62,688,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 357,000 |
| 3 | remainder_Assets | 1,308,000 |
| 4 | LiabilitiesCurrent | 2,650,000 |
| 5 | LiabilitiesNoncurrent | 237,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,033,000 |
| 9 | ResearchAndDevelopmentExpense | 6,334,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -111,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 64,353,000 |
| 1 | Liabilities | 2,887,000 |
| 2 | Expenses | 12,367,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 61,466,000 |
| 5 | NetIncome | -12,478,000 |
| 6 | ComprehensiveNetIncome | -12,478,000 |
| 7 | BaseVar | 39,859,000 |
| 8 | EconomicCapitalRatio | 2.77 |
Edgar->Model Mapping
Feature Distribution
Change over Time
